Heart Disease

What Causes High Blood Pressure?

Blood pressure is the term used to describe the pressure exerted on the arterial walls as blood flows through them. This pressure is at its highest when the heart contracts and pumps blood through the arteries and is called the systolic pressure.

Heart attack and cardiac arrest difference

Heart Failure Causes

Hypertrophic Cardiomyopathy Screening

Cardiac Pharmaceutical Agents

How is Acid Reflux Diagnosed?

Dieting for Obese Children

High Blood Pressure Hypertension

Abdominal Obesity and the Metabolic Syndrome

Causes of Heartburn (Acid Reflux)

Cholesterol Physiology

Hypertrophic Cardiomyopathy Symptoms and Causes

See more featured articles »

Cardiovascular Disease Diagnosis

Hidden Signs of Heart Problems

Obesity and Metabolic Syndrome

Prognosis for Hypoplastic Left Heart Syndrome

High Cholesterol and Stroke Risk

Cardiovascular Disease Research

Drug-Eluting Stent Risks

Drug-Eluting Stent Indications

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Myocardial T1 and T2 Mapping

Heart Failure Symptoms

Heart Attack Questions

Hypertension Diagnosis

Chronic Obstructive Pulmonary Disease Management

What is high cholesterol?

Cardiovascular Drugs

Carotid Artery Stenosis Treatment

Surviving Heart Attack

Hypoplastic Left Heart Syndrome (HLHS)

What is Chronic Obstructive Pulmonary Disease?

Target Heart Rate

Heart Failure Diagnosis

Coronary Artery Disease Prevention

Diagnostic Tests for Hypertrophic Cardiomyopathy

History of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Causes

Coronary Artery Disease Risk Factors

Cardiothoracic Surgery

Drug-Eluting Stent Design

What is Cardiovascular Disease?

What is Cholesterol?

What Causes A Heart Attack?

Heart Rate Reserve

What is Heartburn (Acid Reflux)?

Heart Failure

Structure and Function of the Heart

Coronary Artery Disease Preventive Diets

Heart Failure Prognosis

Hypertension Symptoms and Effects

Diagnosis of Hypoplastic Left Heart Syndrome

Heartburn (Acid Reflux) Prevention

Heart Attack Symptoms

Treatment of Hypoplastic Left Heart Syndrome

Chronic Obstructive Pulmonary Disease Diagnosis

Heart Failure Pathophysiology

Coronary Artery Disease Angina

Chronic Obstructive Pulmonary Disease Symptoms

Lowering Risk for Cardiovascular Disease

Anti-Hypertensive Drugs

Chronic Obstructive Pulmonary Disease Treatment

Cardiothoracic Imaging Techniques

Coronary Artery Disease and Aspirin

Hypertrophic Cardiomyopathy (HCM)

Carotid Artery Stenosis Diagnosis

Heart Failure Terminology

Coronary Artery Disease Treatment

Hypercholesterolemia and Hypocholesterolemia

Coronary Artery Disease and Omega-3 Fatty Acids

Heart Failure Management

High Blood Pressure in Children

Obesity and Blood Pressure

What is Cardiogenic Shock?

LDL Cholesterol and Heart Disease

Heart Attack Diagnosis

Photoplethysmography (PPG) for Heart Disease

Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

Heartburn (Acid Reflux) Treatments

Cardiogenic Shock Symptoms

Percutaneous Closure Procedure

Heart Attack Treatment

COPD and Sleep Apnea

What are Drug-Eluting Stents?

Heartburn (Acid Reflux) Triggers

What is Obesity?

Hypertension Treatment

Heart Disease Biomarkers and Screening Tests

Cardiology Procedures

Obesity in Adults

Artificial Intelligence in Cardiology

Heart Rate Abnormalities

Pulmonary Rehabilitation for COPD

What is a Heart Attack?

Drug-Eluting Stent Alternatives

What is Coronary Artery Disease?

How the Heart Pumps Blood

Cardiovascular Benefits of Blueberries

What is Carotid Artery Stenosis?

Hypertension Risk Factors

Foods that Reduce Heartburn (Acid Reflux)

Why is Visceral Fat Dangerous?

Cardiogenic Shock Treatment

Chronic Obstructive Pulmonary Disease Process

Cardiogenic Shock Diagnosis

Coronary Artery Disease Pathophysiology

Coronary Artery Disease Characteristics

What is Heart Rate?

Hypertrophic Cardiomyopathy Treatments

What is Cardiology?

Heart Failure Classification

Link between Bisphenol A and Increase in Blood Pressure

Latest Heart Disease News and Research

Regular coffee consumption alters gut bacteria and digestive physiology

If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.

10 Nov 2026

Meeting WHO's air pollution guidelines could save nine million lives

Meeting the World Health Organization's recommended annual guidelines for air pollution resulting from fine particulate matter and nitrogen dioxide has the potential to save more than 9 million lives a year in low- and middle-income countries, say University of Cambridge researchers.

10 Nov 2026

Could Ozempic and Wegovy affect unborn babies?

They’re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted pounds.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

In a prospective study of 495,269 UK Biobank participants followed for approximately 13 years, researchers found that coffee consumption was associated with a 7% to 11% lower risk of atrial fibrillation (AF), with the strongest association observed at 2–3 cups daily. Tea consumption showed a more modest and less consistent association, with the authors reporting a 5% lower AF risk at 2–3 cups daily, although the observational findings cannot establish causation.

9 Nov 2026

Late night eating and sleep habits damage gut health, increase metabolic disease risk

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems.

9 Nov 2026

UCLA study identifies lipid imbalance as pulmonary fibrosis trigger

A new UCLA Health study in mice has identified a new potential trigger for pulmonary fibrosis: lipid dysregulation (a fat imbalance) within alveolar macrophages.

9 Nov 2026

Animal study raises questions about semaglutide safety during pregnancy

They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilos.

9 Nov 2026

ACP and OpenEvidence partner to deliver clinical guidance to physicians

The American College of Physicians (ACP), the largest medical specialty organization in the US, and OpenEvidence, the most popular AI for doctors in the United States, announce a collaboration to bring trusted, evidence-based clinical content to physicians at the point of care.

9 Nov 2026

Could a daily supplement keep blood vessels healthier as we age?

The study highlights a multi-compound nutritional supplement's potential to improve blood vessel function and lower blood pressure, aiding vascular health.

9 Nov 2026

Intravenous blood thinner improves heart recovery after cardiogenic shock

For heart attack patients who develop cardiogenic shock-the most serious complication of a heart attack-cangrelor, a potent intravenous blood thinner, resulted in better recovery of heart function when compared to oral antiplatelet therapy.

9 Nov 2026

New mRNA therapy reawakens heart muscle cells to repair damage

Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle.

9 Nov 2026

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum's PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum's lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

From Qureight 9 Nov 2026

Single-pill therapy achieves better long-term blood pressure control

Antihypertensive medications combined into a single pill lowered blood pressure more effectively than typical treatment with multiple pills for patients in Jamaica and Colombia, a study co-led by UT Southwestern Medical Center researchers shows.

8 Nov 2026

Single iron infusion improves exercise capacity in HFpEF patients

A new study by investigators from the Mass General Brigham Heart and Vascular Institute found that a single iron infusion improved exercise capacity in people with heart failure with preserved ejection fraction (HFpEF) and iron deficiency.

8 Nov 2026

Cleaner bedroom air linked to improved blood sugar control

Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in blood sugar experienced by people with prediabetes, a condition in which sugar (glucose) levels are higher than normal, a new study shows.

8 Nov 2026

Early heart procedures do not improve long-term survival in stable heart disease

Patients with stable heart disease and abnormal stress tests who have invasive procedures early in their care do not live longer than those initially treated with drugs and lifestyle changes alone, an international study shows.

8 Nov 2026

Exercise, diet or stress? One lifestyle habit stood out in a heart disease study

A hospital-based case-control study involving 495 adults in Iran found that higher healthy lifestyle scores were associated with lower odds of cardiovascular disease, even after adjustment for demographic and socioeconomic factors. Physical activity and recreation showed the strongest numerical association per questionnaire point, although the observational design could not establish whether healthier habits prevented cardiovascular disease.

8 Nov 2026

ZEUS trial challenges assumptions about targeting inflammation in heart disease

Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought.

8 Nov 2026